Tag #Spatial Biology

How is Nucleai's AI-powered spatial biology platform impacting the efficacy and precision of cancer treatment?

Nucleai, an AI-driven spatial biology company, is enhancing precision medicine by analyzing pathology slides to identify biomarkers and stratify patients for more effective cancer treatments. This leads to improved clinical trial response rates and better patient outcomes, particularly with the rise of targeted therapies like antibody-drug conjugates (ADCs).